MKI67 and neoplasm: The NMP-BE@SAC5A-treated group resulted in a more distinct decrease in the number of Ki67 positive tumor cells compared with that of other groups, demonstrating that NMP-BE@SAC5A markedly restrained proliferation of cancer cells.